Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Rech

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
The Journal of Allergy and Clinical Immunology|October 19, 2020
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based studySatveer K Mahil, Nick Dand, Kayleigh J Mason, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 29, 2025
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre studyRiccardo Balestri, Giulia Odorici, Michela Magnano, et al.
Expert Opinion on Biological Therapy|November 20, 2020
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational studyMarina Talamonti, Marco Galluzzo, Andrea Chiricozzi, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
The Journal of Allergy and Clinical Immunology|October 19, 2020
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based studySatveer K Mahil, Nick Dand, Kayleigh J Mason, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 29, 2025
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre studyRiccardo Balestri, Giulia Odorici, Michela Magnano, et al.
Expert Opinion on Biological Therapy|November 20, 2020
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational studyMarina Talamonti, Marco Galluzzo, Andrea Chiricozzi, et al.
Pageof 6